G. Velasco
发表
M. Martínez-García,
F. Alameda,
M. Gil-Gil,
2022,
Cancers.
I. Chirivella,
D. Castellano,
J. Puente,
2013
.
G. Velasco,
2020,
The Lancet.
M. Gil-Gil,
M. Benavides,
J. Muñoz-Langa,
2020,
Targeted Oncology.
B. Győrffy,
P. Pérez-Segura,
Á. Nagy,
2023,
Current oncology.
B. Győrffy,
A. Pandiella,
P. Pérez-Segura,
2022,
Frontiers in Immunology.
C. Rodríguez-Antona,
J. García-Donas,
A. Font,
2019,
Annals of Oncology.
T. Choueiri,
J. Bellmunt,
A. Fay,
2017,
Oncotarget.
T. Choueiri,
B. Tran,
A. Hansen,
2020
.
D. Castellano,
F. Schutz,
L. Carril-Ajuria,
2019,
Kidney Cancer.
Mark W. Ball,
C. Horak,
R. Motzer,
2018
.
A. Carretero-González,
G. Velasco,
2018
.
S. J. Park,
I. Tannock,
S. Groshen,
2012
.
A. Carrato,
R. Salazar,
I. Durán,
2012
.
L. Paz-Ares,
D. Castellano,
D. Lora,
2017
.
P. Stephens,
S. Signoretti,
T. Choueiri,
2017
.
S. Signoretti,
T. Ho,
A. Hakimi,
2018
.
M. Meyerson,
Catherine J. Wu,
S. Signoretti,
2016
.
Clinical activity of PD1/PDL1 inhibitors in metastatic non-clear cell renal cell carcinoma (nccRCC).
R. Motzer,
T. Choueiri,
D. Feldman,
2017
.
The Cancer Genome Atlas Research Network,
Ashton C. Berger,
J. Weinstein,
2018,
Molecular and Cellular Biology / Genetics.
S. Signoretti,
A. Hakimi,
T. Choueiri,
2016,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
C. Porta,
E. V. Van Allen,
S. Signoretti,
2016,
Clinical Cancer Research.
Chris Sander,
Victor Reuter,
Yiling Lu,
2016,
Cell reports.
G. De Velasco,
P. Maroto,
J. Muñoz-Langa,
2018,
Clinical and Translational Oncology.
A. Carrato,
M. Kudo,
R. Salazar,
2012
.
J. Paramio,
C. Segovia,
M. Martínez-Fernández,
2016
.
T. Powles,
T. Choueiri,
M. Voss,
2023,
The Lancet.
C. Porta,
S. Signoretti,
T. Ho,
2016,
Clinical Cancer Research.
I. Chirivella,
V. Conteduca,
D. Olmos,
2021,
Annals of Oncology.
D. Castellano,
J. Sepúlveda,
Á. Pinto,
2018
.